遺伝子合成の市場規模、シェア、動向分析レポート：方法別（固相合成、チップベース合成、PCRベース酵素合成）、サービス別、用途別、最終用途別、地域別、セグメント別予測、2023年～2030年

遺伝子合成市場の成長と動向

Grand View Research, Inc.の新しいレポートによると、世界の遺伝子合成市場規模は、2023年から2030年にかけて16.1%のCAGRで成長し、2030年には57億8000万米ドルに達すると予測されています。市場の開拓は、合成生物学分野への投資の増加、政府の有利な規制、遺伝子合成市場の技術的進歩によるものです。2022年1月、合成DNAメーカーのツイストバイオサイエンスは、J.P.モルガン・ヘルスケアカンファレンスでEDS技術の開発計画を発表しました。同社は、新規性、低コスト、スカーレス、スケーラビリティに優れた酵素DNA合成技術を確立しました。

研究者の需要増に対応した、技術的に高度な仕様を持つ新規のDNA合成プラットフォームの導入も、全体の成長に寄与しています。例えば、2021年6月、DNAスクリプトは、EDS技術に基づく核酸プリンターであるSYNTAX Systemを発表しました。同様に、2020年12月、エボネティクス株式会社は、アナログ・デバイセズ株式会社と研究提携を締結しました。この契約により、両社はEvonetix社のMicroelectromechanical Systemベースのシリコンチップの改良と商業規模化、およびDNAデスクトップライターの開発で協力しました。

近年、研究者だけでなく、バイオテクノロジーや製薬企業も標的治療への関心を高めています。近年、研究者やバイオテクノロジー企業、製薬企業の間で、標的治療への関心が高まっており、疾病管理の手法として注目されています。近い将来、化学療法や免疫療法と組み合わせた標的療法は大きく発展する可能性があり、遺伝子合成市場における新興・既存両方の競合他社に有利な見通しを示しています。

主なプレイヤーは、製品開発に注力しており、製品提供を拡大するためにパートナーシップやコラボレーションを締結しています。例えば、2022年1月、サーモフィッシャーサイエンティフィック社は、抗体とベクターの生産者であるPeproTech, Inc.の買収を完了させました。この買収は、同社が市場での地位を強化するのに役立つ可能性があります。同様に、2021年7月、GenScriptはGenScript Gene &Cell Engineering Virtual Summitを開催しました。このイベントは、タンパク質設計、創薬、ゲノム編集を強化する合成生物学研究に焦点を当て、同社が顧客基盤を増やすことを可能にするものです。

遺伝子合成市場のレポートハイライト

合成生物学に対する需要の高まりと、合成生物学の研究開発に資金を提供する政府支援の増加が、この市場の成長の要因である

手法別では、固相合成が高精度を提供し、様々な分野や様々な研究目的での応用に有力な技術であることから、2022年に優位に立った

サービス別では、抗体DNA合成が2022年の遺伝子合成市場を独占しました。これは、この分野でサービスを提供しているSynbio offers services、Twist Bioscience Corporationなどの重要なプレーヤーが存在するためです。

用途別では、遺伝子＆細胞治療開発分野が2022年の遺伝子合成市場を独占しました。これは、細胞・遺伝子治療開発のための研究開発プログラムが増加していることに起因しています

最終用途別では、学術・政府研究機関が2022年の遺伝子合成市場を独占、これは遺伝子合成プロセスのほとんどが臨床研究および治験プログラムのための研究環境で実施されるからである

北米は、分子生物学的インフラが確立されていることと、この地域に多数の市場プレーヤーが存在することから、2022年に最も高いシェアを獲得しました。

目次

第1章 遺伝子合成市場：調査手法と範囲

• 市場セグメンテーション
  • セグメントの範囲
  • 地域範囲
• 調査手法
• 情報調達
  • 購入したデータベース
  • GVRの内部データベース
  • 二次情報
  • 1次調査
  • 1次調査の詳細
• 情報またはデータ分析
  • データ分析モデル
• 市場の策定と検証
• モデルの詳細
  • コモディティフロー分析
    • アプローチ1：コモディティフローアプローチ
    • アプローチ2：ボトムアップアプローチを使用した国ごとの市場予測
    • アプローチ2：トップダウンアプローチを使用した国ごとの市場推定
• 世界市場：CAGR計算
• 地域市場：CAGR計算
• 二次情報のリスト
• 目的
• 略語一覧

第2章 遺伝子合成市場：エグゼクティブサマリー

• 遺伝子合成市場：市場の見通し
  • 市場概要

第3章 遺伝子合成市場：業界の見通し

• 市場系列の見通し
  • 親市場系統の見通し
  • 関連/補助的な市場の見通し
• 浸透と成長の見通しのマッピング
• 市場力学
  • 市場促進要因
    • 合成生物学市場への投資の増加
    • 酵素別DNA合成プロセスの出現
    • DNA合成プラットフォームの技術的進歩
    • DNA合成および配列決定の価格の下落
  • 市場抑制要因分析
    • 熟練した専門家の不足
    • 遺伝子合成の誤用
• SWOT分析、要因別（政治と法律、経済と技術）
• 業界分析- ポーターズ
• 償還と規制のシナリオ
• 主要取引と戦略的提携
  • 新製品の発売
  • 取得
  • 拡張
  • パートナーシップ
  • マーケティングとプロモーション

第4章 遺伝子合成市場：競合情勢

• 最近の動向と影響分析、主要な市場参入企業別
  • Ansoff Matrix
• 企業分類
  • イノベーター
    • 市場の差別化要因
• ベンダーの景観
  • 主要なディストリビューターとチャネルパートナーのリスト
  • 主要顧客
  • 主要企業の市場シェア分析、2022年
• 公開企業
  • 競合ダッシュボード分析
• 非公開企業
  • 主要な新興企業のリスト
• 地域ネットワークマップ

第5章 遺伝子合成市場：メソッドビジネス分析

• 遺伝子合成市場：メソッド変動分析
• 固相合成
• チップベース合成
• PCRベースの酵素合成

第6章 遺伝子合成市場：サービス事業分析

• 遺伝子合成市場：サービス変動分析
• 抗体DNA合成
• ウイルスDNA合成
• その他

第7章 遺伝子合成市場：アプリケーションビジネス分析

• 遺伝子合成市場：アプリケーションの変動分析
• 遺伝子および細胞療法の開発
• ワクチン開発
• 病気の診断
• その他

第8章 遺伝子合成市場：エンドユースビジネス分析

• 遺伝子合成市場：最終用途の変動分析
• バイオテクノロジーおよび製薬会社
• 学術研究機関および政府調査機関
• 受託調査機関

第9章 遺伝子合成市場：地域ビジネス分析

• 北米
  • SWOT分析
  • 米国
    • 主要な国のダイナミクス
    • 対象疾患の有病率
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
  • カナダ
    • 主要な国のダイナミクス
    • 対象疾患の有病率
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
• 欧州
  • SWOT分析：
  • ドイツ
    • 主要な国のダイナミクス
    • 対象疾患の有病率
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
  • 英国
    • 主要な国のダイナミクス
    • 対象疾患の有病率
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
  • フランス
    • 主要な国のダイナミクス
    • 対象疾患の有病率
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
  • イタリア
    • 主要な国のダイナミクス
    • 対象疾患の有病率
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
  • スペイン
    • 主要な国のダイナミクス
    • 対象疾患の有病率
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
  • デンマーク
    • 主要な国のダイナミクス
    • 対象疾患の有病率
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
  • スウェーデン
    • 主要な国のダイナミクス
    • 対象疾患の有病率
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
  • ノルウェー
    • 主要な国のダイナミクス
    • 対象疾患の有病率
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
• アジア太平洋地域
  • SWOT分析：
    • 主要な地域のダイナミクス
  • 日本
    • 対象疾患の有病率
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
  • 中国
    • 対象疾患の有病率
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
  • インド
    • 対象疾患の有病率
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
  • 韓国
    • 対象疾患の有病率
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
  • オーストラリア
    • 対象疾患の有病率
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
  • タイ
    • 対象疾患の有病率
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
• ラテンアメリカ
  • SWOT分析：
  • 主な地域のダイナミクス
  • ブラジル
    • 対象疾患の有病率
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
  • メキシコ
    • 対象疾患の有病率
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
  • アルゼンチン
    • 対象疾患の有病率
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
• 中東およびアフリカ（MEA）
  • SWOT分析：
  • 主な地域のダイナミクス
  • 南アフリカ
    • 対象疾患の有病率
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
  • サウジアラビア
    • 対象疾患の有病率
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
  • アラブ首長国連邦
    • 対象疾患の有病率
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
  • クウェート
    • 対象疾患の有病率
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ

第10章 遺伝子合成市場：企業プロファイリング

• 企業プロファイル
  • GenScript
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Brooks Automation, Inc.（GENEWIZ）
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Boster Biological Technology
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Twist Bioscience
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • ProteoGenix, Inc.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Biomatik
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • ProMab Biotechnologies, Inc.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Thermo Fisher Scientific, Inc.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Integrated DNA Technologies, Inc.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • OriGene Technologies, Inc.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
• その他の主なプレーヤーのリスト

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
• Table 4 Global Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
• Table 5 Global Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
• Table 6 Global Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
• Table 7 Global Gene Synthesis Market, by Region, 2018 - 2030 (USD Million)
• Table 8 North America Gene Synthesis Market, by Country, 2018 - 2030 (USD Million)
• Table 9 North America Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
• Table 10 North America Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
• Table 11 North America Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
• Table 12 North America Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
• Table 13 U.S. Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
• Table 14 U.S. Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
• Table 15 U.S. Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
• Table 16 U.S. Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
• Table 17 Canada Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
• Table 18 Canada Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
• Table 19 Canada Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
• Table 20 Canada Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
• Table 21 Europe Gene Synthesis Market, by Country, 2018 - 2030 (USD Million)
• Table 22 Europe Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
• Table 23 Europe Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
• Table 24 Europe Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
• Table 25 Europe Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
• Table 26 Germany Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
• Table 27 Germany Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
• Table 28 Germany Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
• Table 29 Germany Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
• Table 30 UK Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
• Table 31 UK Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
• Table 32 UK Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
• Table 33 UK Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
• Table 34 France Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
• Table 35 France Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
• Table 36 France Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
• Table 37 France Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
• Table 38 Italy Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
• Table 39 Italy Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
• Table 40 Italy Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
• Table 41 Italy Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
• Table 42 Spain Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
• Table 43 Spain Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
• Table 44 Spain Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
• Table 45 Spain Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
• Table 46 Denmark Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
• Table 47 Denmark Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
• Table 48 Denmark Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
• Table 49 Denmark Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
• Table 50 Sweden Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
• Table 51 Sweden Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
• Table 52 Sweden Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
• Table 53 Sweden Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
• Table 54 Norway Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
• Table 55 Norway Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
• Table 56 Norway Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
• Table 57 Norway Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
• Table 58 Asia Pacific Gene Synthesis Market, by Country, 2018 - 2030 (USD Million)
• Table 59 Asia Pacific Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
• Table 60 Asia Pacific Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
• Table 61 Asia Pacific Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
• Table 62 Asia Pacific Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
• Table 63 China Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
• Table 64 China Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
• Table 65 China Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
• Table 66 China Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
• Table 67 Japan Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
• Table 68 Japan Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
• Table 69 Japan Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
• Table 70 Japan Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
• Table 71 India Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
• Table 72 India Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
• Table 73 India Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
• Table 74 India Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
• Table 75 Australia Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
• Table 76 Australia Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
• Table 77 Australia Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
• Table 78 Australia Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
• Table 79 Thailand Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
• Table 80 Thailand Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
• Table 81 Thailand Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
• Table 82 Thailand Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
• Table 83 South Korea Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
• Table 84 South Korea Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
• Table 85 South Korea Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
• Table 86 South Korea Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
• Table 87 Latin America Gene Synthesis Market, by Country, 2018 - 2030 (USD Million)
• Table 88 Latin America Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
• Table 89 Latin America Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
• Table 90 Latin America Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
• Table 91 Latin America Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
• Table 92 Brazil Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
• Table 93 Brazil Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
• Table 94 Brazil Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
• Table 95 Brazil Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
• Table 96 Mexico Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
• Table 97 Mexico Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
• Table 98 Mexico Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
• Table 99 Mexico Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
• Table 100 Argentina Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
• Table 101 Argentina Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
• Table 102 Argentina Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
• Table 103 Argentina Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
• Table 104 Middle East & Africa Gene Synthesis Market, by Country, 2018 - 2030 (USD Million)
• Table 105 Middle East & Africa Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
• Table 106 Middle East & Africa Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
• Table 107 Middle East & Africa Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
• Table 108 Middle East & Africa Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
• Table 109 South Africa Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
• Table 110 South Africa Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
• Table 111 South Africa Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
• Table 112 South Africa Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
• Table 113 Saudi Arabia Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
• Table 114 Saudi Arabia Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
• Table 115 Saudi Arabia Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
• Table 116 Saudi Arabia Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
• Table 117 UAE Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
• Table 118 UAE Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
• Table 119 UAE Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
• Table 120 UAE Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
• Table 121 Kuwait Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
• Table 122 Kuwait Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
• Table 123 Kuwait Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
• Table 124 Kuwait Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information Procurement
• Fig. 3 Primary Research Pattern
• Fig. 4 Market Research Approaches
• Fig. 5 Value Chain - Based Sizing & Forecasting
• Fig. 6 Market Formulation & Validation
• Fig. 7 Gene Synthesis, Market Segmentation
• Fig. 8 Market Snapshot, 2022
• Fig. 9 Market Trends & Outlook
• Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
• Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
• Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
• Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 14 Porter's Five Forces Analysis
• Fig. 15 Market Penetration Vs Growth Prospect Mapping, 2022
• Fig. 16 Global Gene Synthesis Market, : Method Movement Analysis
• Fig. 17 Global Gene Synthesis Market, for Solid - phase Synthesis, 2018 - 2030 (USD Million)
• Fig. 18 Global Gene Synthesis Market, for Chip - based Synthesis, 2018 - 2030 (USD Million)
• Fig. 19 Global Gene Synthesis Market, for PCR - based Enzyme Synthesis, 2018 - 2030 (USD Million)
• Fig. 20 Global Gene Synthesis Market, for Services, Movement Analysis
• Fig. 21 Global Gene Synthesis Market, for Antibody DNA Synthesis, 2018 - 2030 (USD Million)
• Fig. 22 Global Gene Synthesis Market, for Viral DNA Synthesis, 2018 - 2030 (USD Million)
• Fig. 23 Global Gene Synthesis Market, for Others, 2018 - 2030 (USD Million)
• Fig. 24 Global Gene Synthesis Market, for Application, Movement Analysis
• Fig. 25 Global Gene Synthesis Market, for Gene & Cell Therapy Development, 2018 - 2030 (USD Million)
• Fig. 26 Global Gene Synthesis Market, for Vaccine Development, 2018 - 2030 (USD Million)
• Fig. 27 Global Gene Synthesis Market, for Disease Diagnosis, 2018 - 2030 (USD Million)
• Fig. 28 Global Gene Synthesis Market, for Others, 2018 - 2030 (USD Million)
• Fig. 29 Global Gene Synthesis Market, for End - use, Movement Analysis
• Fig. 30 Global Gene Synthesis Market, for Biotechnology and pharmaceutical companies, 2018 - 2030 (USD Million)
• Fig. 31 Global Gene Synthesis Market, for Academic and government research institutes, 2018 - 2030 (USD Million)
• Fig. 32 Global Gene Synthesis Market, for Contract research organizations, 2018 - 2030 (USD Million)
• Fig. 33 Regional Marketplace: Key Takeaways
• Fig. 34 Regional Outlook, 2022 & 2030
• Fig. 35 Global Gene Synthesis Market, : Region Movement Analysis
• Fig. 36 North America Gene Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 37 U.S. Gene Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 38 Canada Gene Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 39 Europe Gene Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 40 Germany Gene Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 41 UK Gene Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 42 France Gene Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 43 Italy Gene Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 44 Spain Gene Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 45 Denmark Gene Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 46 Sweden Gene Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 47 Norway Gene Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 48 Asia Pacific Gene Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 49 Japan Gene Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 50 China Gene Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 51 India Gene Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 52 Australia Gene Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 53 Thailand Gene Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 54 South Korea Gene Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 55 Latin America Gene Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 56 Brazil Gene Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 57 Mexico Gene Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 58 Argentina Gene Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 59 Middle East and Africa Gene Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 60 South Africa Gene Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 61 Saudi Arabia Gene Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 62 UAE Gene Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 63 Kuwait Gene Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 64 Ansoff Matrix
• Fig. 65 Market differentiators
• Fig. 66 Key company market share analysis, 2022
• Fig. 67 Company market position analysis
• Fig. 68 Competitive dashboard analysis
• Fig. 69 Regional network map

Gene Synthesis Market Growth & Trends:

The global gene synthesis market size is expected to reach USD 5.78 billion by 2030, registering a CAGR of 16.1% from 2023 to 2030 according to a new report by Grand View Research, Inc. Development of the market is due to the growing investment in the synthetic biology field, favorable government regulations, and technological advancements in the gene synthesis market. In January 2022, synthetic DNA manufacturer Twist Bioscience announced plans of developing EDS technology at the J.P. Morgan Health Care Conference. The company established an enzymatic DNA synthesis technology that is novel, low-cost, scarless, and scalable.

The introduction of novel DNA synthesis platforms with technologically advanced specifications that address the increased demand of researchers is also contributing to the overall growth. For instance, in June 2021, DNA Script introduced the SYNTAX System, which is the nucleic acid printer based on EDS technology. Similarly, in December 2020, Evonetix Ltd. entered into a research collaboration with Analog Devices, Inc. Under the terms of the agreement, the companies collaborated on Evonetix's Microelectromechanical System-based silicon chips' improvement and commercial scale-up, as well as the development of a DNA desktop writer.

Researchers, as well as biotechnology and pharmaceutical corporations, have become increasingly interested in targeted therapy during recent years. It has become a popular method of disease management. In the near future, targeted therapy in conjunction with chemotherapy and immunotherapy is likely to develop significantly, presenting lucrative prospects for both emerging & established competitors in the gene synthesis market.

Key players are focusing on product development and are entering into partnerships and collaborations to expand their product offerings. For instance, In January 2022, Thermo Fisher Scientific, Inc. completed the acquisition of PeproTech, Inc.- a producer of antibodies and vectors. This acquisition may help the company strengthen its position in the market. Similarly, in July 2021, GenScript hosted the GenScript Gene & Cell Engineering Virtual Summit. This event focused on highlighting synthetic biology research to enhance protein design, drug discovery, and genome editing, enabling the company to increase its customer base.

Gene Synthesis Market Report Highlights:

• The growth is attributed to the growing demand for the synthetic biology, coupled with increasing government support to offer funds for R&D initiatives in synthetic biology

• By method, solid-phase synthesis dominated in 2022 as it offers high accuracy and is a prominent technology for the applications in several fields and for various research purposes

• By services, antibody DNA synthesis dominated the gene synthesis market in 2022, owing to the presence of significant players such as Synbio offers services, Twist Bioscience Corporation, and others, offering services in this segment

• By application, the gene & cell therapy development segment dominated the gene synthesis market in 2022. This is attributed to the growing number of R&D programs for the development of cell and gene therapies

• By end-use, academic and government research institute dominated the gene synthesis market in 2022, as most of the gene synthesis process is performed in the research settings for clinical research and investigational programs

• North America captured the highest share in 2022 owing to the well-established molecular biology infrastructure along with the presence of a significant number of market players in the region

Table of Contents

Chapter 1 Gene Synthesis Market: Methodology And Scope

• 1.1 Market Segmentation
  • 1.1.1 Segment Scope
  • 1.1.2 Regional Scope
  • 1.1.3 Estimates And Forecast Timeline
• 1.2 Research Methodology
• 1.3 Information Procurement
  • 1.3.1 Purchased Database
  • 1.3.2 GVR's Internal Database
  • 1.3.3 Secondary Sources
  • 1.3.4 Primary Research
  • 1.3.5 Details Of Primary Research
• 1.4 Information Or Data Analysis
  • 1.4.1 Data Analysis Models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.6.1 Commodity Flow Analysis
    • 1.6.1.1 Approach 1: Commodity Flow Approach
    • 1.6.1.2 Approach 2: Country Wise Market Estimation Using Bottom Up Approach
    • 1.6.1.3 Approach 2: Country Wise Market Estimation Using Top Down Approach
• 1.7 Global Market: CAGR Calculation
• 1.8 Regional Market: CAGR Calculation
• 1.9 List Of Secondary Sources
• 1.10 Objectives
  • 1.10.1 Objective 1:
  • 1.10.2 Objective 2:
• 1.11 List of Abbreviations

Chapter 2 Gene Synthesis Market: Executive Summary

• 2.1 Gene Synthesis Market: Market Outlook
  • 2.1.1 Market Summary

Chapter 3 Gene Synthesis Market: Industry Outlook

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent Market Lineage Outlook
  • 3.1.2 Related/Ancillary Market Outlook
• 3.2 Penetration & Growth Prospect Mapping
• 3.3 Market Dynamics
  • 3.3.1 Market Drivers
    • 3.3.1.1 Rising investment in synthetic biology market
    • 3.3.1.2 Advent of enzymatic DNA synthesis process
    • 3.3.1.3 Technological advancements in the DNA synthesis platforms
    • 3.3.1.4 Declining price of DNA synthesis & sequencing
  • 3.3.2 Market restraint Analysis
    • 3.3.2.1 Lack of skilled professionals
    • 3.3.2.2 Misuse of gene synthesis
• 3.4 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• 3.5 Industry Analysis - Porter's
• 3.6 Reimbursement & Regulatory Scenario
• 3.7 Major Deals & Strategic Alliances
  • 3.7.1 New Product Launch
  • 3.7.2 Acquisition
  • 3.7.3 Expansion
  • 3.7.4 Partnerships
  • 3.7.5 Marketing & Promotions

Chapter 4 Gene Synthesis Market: Competitive Landscape

• 4.1 Recent Developments & Impact Analysis, By Key Market Participants
  • 4.1.1 Ansoff Matrix
• 4.2 Company Categorization
  • 4.2.1 Innovators
    • 4.2.1.1 Market Differentiators
• 4.3 Vendor Landscape
  • 4.3.1 List Of Key Distributors And Channel Partners
  • 4.3.2 Key Customers
  • 4.3.3 Key Company Market Share Analysis, 2022
• 4.4 Public Companies
  • 4.4.1 Competitive Dashboard Analysis
• 4.5 Private Companies
  • 4.5.1 List Of Key Emerging Companies
• 4.6 Regional Network Map

Chapter 5 Gene Synthesis Market: Method Business Analysis

• 5.1 Gene Synthesis Market: Method Movement Analysis
• 5.2 Solid-phase Synthesis
  • 5.2.1 Solid-phase Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
• 5.3 Chip-based Synthesis
  • 5.3.1 Chip-based Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
• 5.4 PCR-based Enzyme Synthesis
  • 5.4.1 PCR-based Enzyme Synthesis market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6 Gene Synthesis Market: Services Business Analysis

• 6.1 Gene Synthesis Market: Services Movement Analysis
• 6.2 Antibody DNA Synthesis
  • 6.2.1 Antibody DNA Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
• 6.3 Viral DNA Synthesis
  • 6.3.1 Viral DNA Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
• 6.4 Others
  • 6.4.1 Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7 Gene Synthesis Market: Application Business Analysis

• 7.1 Gene Synthesis Market: Application Movement Analysis
• 7.2 Gene & Cell Therapy Development
  • 7.2.1 Gene & Cell Therapy Development market estimates and forecast, 2018 - 2030 (USD Million)
• 7.3 Vaccine Development
  • 7.3.1 Vaccine Development market estimates and forecast, 2018 - 2030 (USD Million)
• 7.4 Disease Diagnosis
  • 7.4.1 Disease Diagnosis market estimates and forecast, 2018 - 2030 (USD Million)
• 7.5 Others
  • 7.5.1 Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8 Gene Synthesis Market: End-use Business Analysis

• 8.1 Gene Synthesis Market: End-use Movement Analysis
• 8.2 Biotechnology and Pharmaceutical Companies
  • 8.2.1 Biotechnology and Pharmaceutical Companies market estimates and forecast, 2018 - 2030 (USD Million)
• 8.3 Academic and Government Research Institutes
  • 8.3.1 Academic And Government Research Institutes market estimates and forecast, 2018 - 2030 (USD Million)
• 8.4 Contract Research Organizations
  • 8.4.1 Contract Research Organizations market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9 Gene Synthesis Market: Regional Business Analysis

• 9.1 North America
  • 9.1.1 Swot Analysis
    • 9.1.1.1 North America Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.1.2 U.S.
    • 9.1.2.1 Key Country Dynamics
    • 9.1.2.2 Target Disease Prevalence
    • 9.1.2.3 Competitive Scenario
    • 9.1.2.4 Regulatory Framework
    • 9.1.2.5 Reimbursement Scenario
    • 9.1.2.6 U.S. Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.1.3 CANADA
    • 9.1.3.1 Key Country Dynamics
    • 9.1.3.2 Target Disease Prevalence
    • 9.1.3.3 Competitive Scenario
    • 9.1.3.4 Regulatory Framework
    • 9.1.3.5 Reimbursement Scenario
    • 9.1.3.6 Canada Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 9.2 Europe
  • 9.2.1 SWOT Analysis:
    • 9.2.1.1 Europe Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.2.2 Germany
    • 9.2.2.1 Key Country Dynamics
    • 9.2.2.2 Target Disease Prevalence
    • 9.2.2.3 Competitive Scenario
    • 9.2.2.4 Regulatory Framework
    • 9.2.2.5 Reimbursement Scenario
    • 9.2.2.6 Germany Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.2.3 UK
    • 9.2.3.1 Key Country Dynamics
    • 9.2.3.2 Target Disease Prevalence
    • 9.2.3.3 Competitive Scenario
    • 9.2.3.4 Regulatory Framework
    • 9.2.3.5 Reimbursement Scenario
    • 9.2.3.6 UK Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.2.4 FRANCE
    • 9.2.4.1 Key Country Dynamics
    • 9.2.4.2 Target Disease Prevalence
    • 9.2.4.3 Competitive Scenario
    • 9.2.4.4 Regulatory Framework
    • 9.2.4.5 Reimbursement Scenario
    • 9.2.4.6 France Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.2.5 Italy
    • 9.2.5.1 Key Country Dynamics
    • 9.2.5.2 Target Disease Prevalence
    • 9.2.5.3 Competitive Scenario
    • 9.2.5.4 Regulatory Framework
    • 9.2.5.5 Reimbursement Scenario
    • 9.2.5.6 Italy Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.2.6 Spain
    • 9.2.6.1 Key Country Dynamics
    • 9.2.6.2 Target Disease Prevalence
    • 9.2.6.3 Competitive Scenario
    • 9.2.6.4 Regulatory Framework
    • 9.2.6.5 Reimbursement Scenario
    • 9.2.6.6 Spain Cell & Gene Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.2.7 Denmark
    • 9.2.7.1 Key Country Dynamics
    • 9.2.7.2 Target Disease Prevalence
    • 9.2.7.3 Competitive Scenario
    • 9.2.7.4 Regulatory Framework
    • 9.2.7.5 Reimbursement Scenario
    • 9.2.7.6 Denmark Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.2.8 Sweden
    • 9.2.8.1 Key Country Dynamics
    • 9.2.8.2 Target Disease Prevalence
    • 9.2.8.3 Competitive Scenario
    • 9.2.8.4 Regulatory Framework
    • 9.2.8.5 Reimbursement Scenario
    • 9.2.8.6 Sweden Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.2.9 Norway
    • 9.2.9.1 Key Country Dynamics
    • 9.2.9.2 Target Disease Prevalence
    • 9.2.9.3 Competitive Scenario
    • 9.2.9.4 Regulatory Framework
    • 9.2.9.5 Reimbursement Scenario
    • 9.2.9.6 Norway Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 9.3 Asia Pacific
  • 9.3.1 Swot Analysi:
    • 9.3.1.1 Key Region Dynamics
    • 9.3.1.2 Asia Pacific Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.3.2 Japan
    • 9.3.2.1 Target Disease Prevalence
    • 9.3.2.2 Competitive Scenario
    • 9.3.2.3 Regulatory Framework
    • 9.3.2.4 Reimbursement Scenario
    • 9.3.2.5 Japan Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.3.3 China
    • 9.3.3.1 Target Disease Prevalence
    • 9.3.3.2 Competitive Scenario
    • 9.3.3.3 Regulatory Framework
    • 9.3.3.4 Reimbursement Scenario
    • 9.3.3.5 China Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.3.4 India
    • 9.3.4.1 Target Disease Prevalence
    • 9.3.4.2 Competitive Scenario
    • 9.3.4.3 Regulatory Framework
    • 9.3.4.4 Reimbursement Scenario
    • 9.3.4.5 India Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.3.5 South Korea
    • 9.3.5.1 Target Disease Prevalence
    • 9.3.5.2 Competitive Scenario
    • 9.3.5.3 Regulatory Framework
    • 9.3.5.4 Reimbursement Scenario
    • 9.3.5.5 South Korea Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.3.6 Australia
    • 9.3.6.1 Target Disease Prevalence
    • 9.3.6.2 Competitive Scenario
    • 9.3.6.3 Regulatory Framework
    • 9.3.6.4 Reimbursement Scenario
    • 9.3.6.5 Australia Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.3.7 Thailand
    • 9.3.7.1 Target Disease Prevalence
    • 9.3.7.2 Competitive Scenario
    • 9.3.7.3 Regulatory Framework
    • 9.3.7.4 Reimbursement Scenario
    • 9.3.7.5 Thailand Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 9.4 Latin America
  • 9.4.1 Swot Analysis:
  • 9.4.2 Key Regional Dynamics
    • 9.4.2.1 Latin America Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4.3 Brazil
    • 9.4.3.1 Target Disease Prevalence
    • 9.4.3.2 Competitive Scenario
    • 9.4.3.3 Regulatory Framework
    • 9.4.3.4 Reimbursement Scenario
    • 9.4.3.5 Brazil Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4.4 Mexico
    • 9.4.4.1 Target Disease Prevalence
    • 9.4.4.2 Competitive Scenario
    • 9.4.4.3 Regulatory Framework
    • 9.4.4.4 Reimbursement Scenario
    • 9.4.4.5 Mexico Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4.5 Argentina
    • 9.4.5.1 Target Disease Prevalence
    • 9.4.5.2 Competitive Scenario
    • 9.4.5.3 Regulatory Framework
    • 9.4.5.4 Reimbursement Scenario
    • 9.4.5.5 Argentina Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 9.5 Middle East & Africa (MEA)
  • 9.5.1 SWOT ANALYSIS:
  • 9.5.2 KEY regional DYNAMICS
    • 9.5.2.1 Middle East & Africa Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5.3 SOUTH AFRICA
    • 9.5.3.1 Target Disease Prevalence
    • 9.5.3.2 Competitive Scenario
    • 9.5.3.3 Regulatory Framework
    • 9.5.3.4 Reimbursement Scenario
    • 9.5.3.5 south Africail Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5.4 Saudi Arabia
    • 9.5.4.1 Target Disease Prevalence
    • 9.5.4.2 Competitive Scenario
    • 9.5.4.3 Regulatory Framework
    • 9.5.4.4 Reimbursement Scenario
    • 9.5.4.5 Saudi Arabia Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5.5 UAE
    • 9.5.5.1 Target Disease Prevalence
    • 9.5.5.2 Competitive Scenario
    • 9.5.5.3 Regulatory Framework
    • 9.5.5.4 Reimbursement Scenario
    • 9.5.5.5 UAE Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5.6 Kuwait
    • 9.5.6.1 Target Disease Prevalence
    • 9.5.6.2 Competitive Scenario
    • 9.5.6.3 Regulatory Framework
    • 9.5.6.4 Reimbursement Scenario
    • 9.5.6.5 Kuwait Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 10 Gene Synthesis Market: Company Profiling

• 10.1 Company Profiles
  • 10.1.1 GenScript
    • 10.1.1.1 Company overview
    • 10.1.1.2 Financial performance
    • 10.1.1.3 Product benchmarking
    • 10.1.1.4 Strategic initiatives
  • 10.1.2 Brooks Automation, Inc. (GENEWIZ)
    • 10.1.2.1 Company overview
    • 10.1.2.2 Financial performance
    • 10.1.2.3 Product benchmarking
    • 10.1.2.4 Strategic initiatives
  • 10.1.3 Boster Biological Technology
    • 10.1.3.1 Company overview
    • 10.1.3.2 Financial performance
    • 10.1.3.3 Product benchmarking
    • 10.1.3.4 Strategic initiatives
  • 10.1.4 Twist Bioscience
    • 10.1.4.1 Company overview
    • 10.1.4.2 Financial performance
    • 10.1.4.3 Product benchmarking
    • 10.1.4.4 Strategic initiatives
  • 10.1.5 ProteoGenix, Inc.
    • 10.1.5.1 Company overview
    • 10.1.5.2 Financial performance
    • 10.1.5.3 Product benchmarking
    • 10.1.5.4 Strategic initiatives
  • 10.1.6 Biomatik
    • 10.1.6.1 Company overview
    • 10.1.6.2 Financial performance
    • 10.1.6.3 Product benchmarking
    • 10.1.6.4 Strategic initiatives
  • 10.1.7 ProMab Biotechnologies, Inc.
    • 10.1.7.1 Company overview
    • 10.1.7.2 Financial performance
    • 10.1.7.3 Product benchmarking
    • 10.1.7.4 Strategic initiatives
  • 10.1.8 Thermo Fisher Scientific, Inc.
    • 10.1.8.1 Company overview
    • 10.1.8.2 Financial performance
    • 10.1.8.3 Product benchmarking
    • 10.1.8.4 Strategic initiatives
  • 10.1.9 Integrated DNA Technologies, Inc.
    • 10.1.9.1 Company overview
    • 10.1.9.2 Financial performance
    • 10.1.9.3 Product benchmarking
    • 10.1.9.4 Strategic initiatives
  • 10.1.10 OriGene Technologies, Inc.
    • 10.1.10.1 Company overview
    • 10.1.10.2 Financial performance
    • 10.1.10.3 Product benchmarking
    • 10.1.10.4 Strategic initiatives
• 10.2 List of Other Key Players